HPAPI and ADC manufacturing facility, Merck KGaA, Wisconsin, USA
Darmstadt headquartered Merck KGaA, a leading science and technology company operating in the U.S. & Canada as MilliporeSigma, has announced a
Read more
Oncology
Merck to licence two preclinical immuno oncology programs from F-star
Two additional preclinical discovery programs will be added to the Merck KGaA and F-star Therapeutics collaboration. Merck KGaA, Darmstadt, Germany
Read more
FDA clears Deciphera Pharmaceuticals’ QINLOCK™ (ripretinib) for GIST
Deciphera Pharmaceuticals, Inc. has revealed that QINLOCK™ (ripretinib) was formally authorised by the U.S. Food and Drug Administration (FDA) for
Read more
FDA approves Lynparza as maintenance treatment with bevacizumab for HRD-positive ovarian cancer
AstraZeneca and Merck & Co have received the FDA’s approval for Lynparza (olaparib) as 1st-line maintenance treatment with bevacizumab for
Read more
Inovio Pharmaceuticals Stock up 16.36% as HPV drug shows promise
Inovio Pharmaceuticals stock soared by +16.36% on Friday, as HPV drug VGX-3100 showed promise in Phase 2 Trial. Shares of
Read more
Gilead to acquire immuno-oncology company Forty Seven for $4.9 Billion
Gilead to acquire clinical-stage immuno-oncology company Forty Seven for $4.9 Billion Gilead Sciences, Inc. and Forty Seven, Inc. announced that
Read more
Paris-Saclay Research Institute, Servier Group
The Servier Group has commenced the construction of its ultra-modern Research Institute in the Paris-Saclay cluster in France. Covering approximately 45,000 m2,
Read more
Skin cancer drug trial boosts CK Life Sciences stock by 240%
CK Life Sciences stock jumps 240% as skin cancer drug trial looks promising. Seviprotimut-L could serve as a significant innovation in the vaccine-based treatment of melanoma.
Read more